AAAAAA
Results:
1-21
|
Results: 21
Authors:
Falconnier, AD
Haefeli, WE
Schoenenberger, RA
Surber, C
Martin-Facklam, M
Citation: Ad. Falconnier et al., Drug dosage in patients with renal failure optimized by immediate concurrent feedback, J GEN INT M, 16(6), 2001, pp. 369-375
Authors:
Loehrer, FMT
Tschopl, M
Angst, CP
Litynski, P
Jager, K
Fowler, B
Haefeli, WE
Citation: Fmt. Loehrer et al., Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease, ATHEROSCLER, 154(1), 2001, pp. 147-154
Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvement
Authors:
Tayrouz, Y
Ganssmann, B
Ding, R
Klingmann, A
Aderjan, R
Burhenne, J
Haefeli, WE
Mikus, G
Citation: Y. Tayrouz et al., Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvement, CLIN PHARM, 70(5), 2001, pp. 405-414
Authors:
Schlienger, RG
Haefeli, WE
Jick, H
Meier, CR
Citation: Rg. Schlienger et al., Risk of cataract in patients treated with statins, ARCH IN MED, 161(16), 2001, pp. 2021-2026
Authors:
Martin-Facklam, M
Drewe, J
Haefeli, WE
Citation: M. Martin-facklam et al., Drug interactions with the cytochrome P 450 system, DEUT MED WO, 125(3), 2000, pp. 63-67
Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine
Authors:
Drewe, J
Ball, HA
Beglinger, C
Peng, B
Kemmler, A
Schachinger, H
Haefeli, WE
Citation: J. Drewe et al., Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine, BR J CL PH, 50(3), 2000, pp. 237-246
Authors:
Hotz, MA
Ritz, R
Linder, L
Scollo-Lavizzari, G
Haefeli, WE
Citation: Ma. Hotz et al., Auditory and electroencephalographic effects of midazolam and alpha-hydroxy-midazolam in healthy subjects, BR J CL PH, 49(1), 2000, pp. 72-79
Authors:
Romerio, SC
Linder, L
Flammer, J
Haefeli, WE
Citation: Sc. Romerio et al., Correlation between apolipoprotein B and endothelin-1-induced vasoconstriction in humans, PEPTIDES, 21(6), 2000, pp. 871-874
Authors:
Arnet, I
Haefeli, WE
Citation: I. Arnet et We. Haefeli, Overconsumption detected by electronic drug monitoring requires subtle interpretation, CLIN PHARM, 67(1), 2000, pp. 44-47
Authors:
Muller-Schweinitzer, E
Brett, W
Zerkowski, HR
Haefeli, WE
Citation: E. Muller-schweinitzer et al., The mechanism of cryoinjury: In vitro studies on human internal mammary arteries, BR J PHARM, 130(3), 2000, pp. 636-640
Authors:
Reber, A
Budmiger, B
Wenk, M
Haefeli, WE
Wolff, T
Bein, T
Skarvan, K
Citation: A. Reber et al., Inspired oxygen fraction after cardiopulmonary bypass: effects on pulmonary function with regard to endothelin-1 concentrations and venous admixture, BR J ANAEST, 84(5), 2000, pp. 565-570
Authors:
Schlienger, RG
Luscher, TF
Schoenenberger, RA
Haefeli, WE
Citation: Rg. Schlienger et al., Academic detailing improves identification and reporting of adverse drug events, PHARM WORLD, 21(3), 1999, pp. 110-115
Authors:
Ratz, AE
Schlienger, RG
Linder, L
Langewitz, W
Haefeli, WE
Citation: Ae. Ratz et al., Pharmacokinetics and pharmacodynamics of clomethiazole after oral and rectal administration in healthy subjects, CLIN THER, 21(5), 1999, pp. 829-840
Authors:
Arnet, I
Schoenenberger, RA
Spiegel, R
Haefeli, WE
Citation: I. Arnet et al., Conviction as a basis for compliance and strategies for improving compliance, SCHW MED WO, 129(41), 1999, pp. 1477-1486
Authors:
Schuerch, LV
Nyfeler, J
Holder, G
Surber, C
Haefeli, WE
Citation: Lv. Schuerch et al., Tablets in stool? An everyday problem!, SCHW MED WO, 129(17), 1999, pp. 670-673
Authors:
Fuchs, P
Haefeli, WE
Ledermann, HR
Wenk, M
Citation: P. Fuchs et al., Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities, EUR J CL PH, 54(11), 1999, pp. 869-876
Authors:
Tsakiris, DA
Tschopl, M
Jager, K
Haefeli, WE
Wolf, F
Marbet, GA
Citation: Da. Tsakiris et al., Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease, ATHEROSCLER, 142(1), 1999, pp. 193-200
Authors:
Todesco, L
Angst, C
Litynski, P
Loehrer, F
Fowler, B
Haefeli, WE
Citation: L. Todesco et al., Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and age, EUR J CL IN, 29(12), 1999, pp. 1003-1009
Authors:
Romerio, SC
Linder, L
Haefeli, WE
Citation: Sc. Romerio et al., Neurokinin-1 receptor antagonist R116301 inhibits substance P-induced venodilation, CLIN PHARM, 66(5), 1999, pp. 522-527
Authors:
Haller, L
Sossouhounto, R
Coulibaly, IM
Dosso, M
Kone, M
Adom, H
Meyer, UA
Betschart, B
Wenk, M
Haefeli, WE
Lobognon, LR
Porquet, M
Kabore, G
Sorenson, F
Reber-Liske, R
Sturchler, D
Citation: L. Haller et al., Isoniazid plus sulphadoxine-pyrimethamine can reduce morbidity of HIV-positive patients treated for tuberculosis in Africa: A controlled clinical trial, CHEMOTHERA, 45(6), 1999, pp. 452-465
Authors:
Rothen, JP
Haefeli, WE
Meyer, UA
Todesco, L
Wenk, M
Citation: Jp. Rothen et al., Acetaminophen is an inhibitor of hepatic N-acetyltransferase 2 in vitro and in vivo, PHARMACOGEN, 8(6), 1998, pp. 553-559
Risultati:
1-21
|